Lead Sponsor

Glaukos Corporation

Age

45 - No limit years

Sex

ALL

Healthy Volunteers

No

•clinically significant age-related cataract eligible for phacoemulsification in the study eye
•open-angle glaucoma or ocular hypertension in the study eye
•successful, uncomplicated cataract surgery using small incision phacoemulsification cataract surgery and insertion of a foldable posterior chamber IOL

•unmedicated (washed out) IOP of \>36 mmHg in the study eye
•hypersensitivity to travoprost or any other components of the travoprost intraocular implant
•vertical cup/disc ratio \> 0.8 in the study eye
•best spectacle corrected visual acuity of worse than 20/80 in the fellow eye
•any ocular disease or condition that, in the opinion of the investigator, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study